Summary: In a single-blind randomized controlled trial of 60 adults with type 2 diabetes in Iran, a six-week family-centered empowerment program improved patient-reported illness acceptance (47.1 vs 34.66; p<0.001) and self-management (36.37 vs 23.26; p<0.001) versus usual care at six weeks. No metabolic outcomes such as HbA1c were measured, and follow-up was short.
PICO Summary
| Element | Detail |
|---|---|
| Population | 60 adults with type 2 diabetes; single-center, single-blind RCT with block randomization, Iran. |
| Intervention | Family-centered empowerment program (FCEP) of educational and supportive sessions for patients and their families (n=30). |
| Comparison | Usual care with standard medical and educational support, no structured family involvement (n=30). |
| Outcome | Illness acceptance (DAS) at six weeks: 47.1 ± 5.72 (FCEP) vs 34.66 ± 10.54 (control), p<0.001; immediately post-intervention 41.79 vs 34.86, p=0.008. Self-management (DSMQ) at six weeks: 36.37 ± 2.39 vs 23.26 ± 3.11, p<0.001; immediately post-intervention 30.93 vs 23.63, p<0.001. Baseline groups did not differ (p=0.396 and p=0.305). No 95% CIs, ARR, NNT, or metabolic endpoints (e.g. HbA1c) were reported. |
Family-Centered Empowerment in T2D
RCT · type 2 diabetes · 6 weeks
A six-week family-centered empowerment program raised patient-reported illness acceptance and self-management versus usual care. All outcomes were questionnaire scores with no HbA1c or metabolic endpoint, so glycaemic benefit is unproven.
Expert Commentary
This single-blind randomized trial is presented as a positive feasibility-scale study, and the verdict should be read as such: a structured family-centered empowerment program produced statistically significant gains in two patient-reported scales, illness acceptance and self-management, with effects that were already evident immediately after the sessions and were larger at six weeks. The signal is internally consistent, and balanced baseline scores support that randomization worked. The principal limitation is that every outcome is a questionnaire score over a six-week horizon, with no metabolic anchor such as HbA1c, weight, or blood pressure, so it cannot yet be said whether better self-reported behaviour translates into glycaemic benefit or durable change. The sample is small at 60 participants from a single center, confidence intervals and absolute effect measures were not reported, and patients could not be blinded to a behavioural intervention, which inflates self-reported outcomes. Can I use this with my patients? Partly, and as a complement rather than a proven treatment: the program is a reasonable model for clinicians, particularly nurse-led teams, who already involve families in diabetes education, but it is not yet evidence that it lowers HbA1c. Larger, longer trials reporting metabolic endpoints and effect sizes with confidence intervals are needed before this is positioned as anything more than a promising engagement strategy.
References
Amani N, Nazari AM, Sanaie N, Abbasi A, Borhani F. Effects of family-centered empowerment program on illness acceptance and self-management of patients with type 2 diabetes: a randomized controlled trial. Sci Rep. 2025;15(1):21615. doi:10.1038/s41598-025-05833-0